Probiotic plus lipid-lowering for pancreatitis from high triglycerides
Treatments studied
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests if adding a probiotic (Bacillus subtilis and Enterococcus faecium) to standard lipid-lowering therapy helps people with mild pancreatitis caused by very high triglycerides. It aims to see if the combination reduces inflammation and speeds recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute pancreatitis from high triglycerides (blood fat level above 11.3 mmol/L or between 5.65-11.3 mmol/L with milky-looking blood).
- You are between 18 and 65 years old.
- You came to the hospital within 72 hours of your pain starting and have been classified as having mild pancreatitis (no organ failure or complications in the first 48 hours).
- You do not have diabetes, severe liver or kidney problems, active infection, cancer, or a weak immune system.
- You have not taken antibiotics, probiotics, or certain digestive drugs in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fecal microbiota transplant (FMT) can help prevent infections in people with moderately severe or severe acute pancreatitis. You may qualify if you are between 18 and 75, have had pancreatitis for 15 to 21 days, and already have a feeding tube in place.
This trial tests whether taking a probiotic called Bifidobacterium longum can help people with acute pancreatitis recover better. The study compares the probiotic against a placebo (a pill with no active ingredient) to see if it reduces inflammation and complications.
This trial tests if adding a medication called evolocumab to usual cholesterol-lowering treatment helps people who have had a specific type of pancreatitis caused by very high triglycerides (a type of fat in the blood). It aims to reduce triglyceride levels and prevent another episode.
This study looks at people with acute pancreatitis caused by very high blood fat levels (triglycerides). It aims to collect information to better understand and treat this condition.
This trial tests a supplement called tributyrin (related to butyrate) to see if it can help prevent complications from acute pancreatitis when given early after diagnosis. It is for people having their first episode of pancreatitis, not for those with certain causes or weakened immune systems.
This trial tests a medication (a GLP-1 agonist) to see if it can prevent another pancreatitis attack caused by very high triglycerides. If you recently had such an attack, this treatment might lower your risk of it happening again.
Hear when a new Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.